861 related articles for article (PubMed ID: 19568011)
21. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
Freund BJ; Schwartz M
J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.
Cohen BL; Barboglio P; Rodriguez D; Gousse AE
Neurourol Urodyn; 2009; 28(3):205-8. PubMed ID: 19058190
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial.
Patti R; Almasio PL; Arcara M; Sammartano S; Romano P; Fede C; Di Vita G
Dis Colon Rectum; 2006 Nov; 49(11):1741-8. PubMed ID: 16990976
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection.
Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O
Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
Vo AH; Satori R; Jabbari B; Green J; Killgore WD; Labutta R; Campbell WW
Aviat Space Environ Med; 2007 May; 78(5 Suppl):B113-8. PubMed ID: 17547312
[TBL] [Abstract][Full Text] [Related]
26. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy.
Lowe K; Novak I; Cusick A
Dev Med Child Neurol; 2006 Mar; 48(3):170-5. PubMed ID: 16483391
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
[TBL] [Abstract][Full Text] [Related]
28. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
30. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
31. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Arch Phys Med Rehabil; 2006 Dec; 87(12):1551-8. PubMed ID: 17141633
[TBL] [Abstract][Full Text] [Related]
32. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
34. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
Park H; Shin S; Shin HS; Kim HW; Kim DW; Lee DH
Clin Orthop Relat Res; 2016 Dec; 474(12):2705-2711. PubMed ID: 27506971
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
37. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
38. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.
Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A
Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908
[TBL] [Abstract][Full Text] [Related]
39. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
40. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]